IMMUNODEFICIENCY
Clinical trials for IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could make stem cell transplants safer for rare immune disorder
Disease control OngoingThis phase II trial tests whether a new drug called Briquilimab can make stem cell transplants safer for people with GATA2 deficiency, a rare genetic condition that weakens the immune system and raises the risk of infections and blood cancers. The study involves 13 participants a…
Matched conditions: IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Holistic education study for stress withdrawn before starting
Knowledge-focused TerminatedThis study was designed to test a holistic education program for stress management in people from colonized English-speaking countries. It aimed to help with conditions like stress, PTSD, anxiety, and fatigue using pastoral counseling and self-care activities. However, the study …
Matched conditions: IMMUNODEFICIENCY
Phase: NA • Sponsor: Goddess Zena I. Jones • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Rapid test may speed up right antibiotics for pneumonia in vulnerable ICU patients
Knowledge-focused OngoingThis study tests whether a rapid PCR test can help doctors choose the right antibiotics within 24 hours for immunocompromised ICU patients with pneumonia. Standard lab tests take days, which can lead to incorrect or overly broad antibiotics. The trial involves 31 adults with weak…
Matched conditions: IMMUNODEFICIENCY
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC